Jonathan Meinke, Karin U Löffler, Yannick N Liermann, Frank G Holz, Martina C Herwig-Carl
{"title":"[Characterization of periocular basal cell carcinoma in patients ≤ 50 years from 1996-2024 : A retrospective analysis at a university eye clinic].","authors":"Jonathan Meinke, Karin U Löffler, Yannick N Liermann, Frank G Holz, Martina C Herwig-Carl","doi":"10.1007/s00347-025-02273-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Basal cell carcinoma (BCC) is rare in patients ≤ 50 years and can be associated with tumor predisposition syndromes (TPDS). The BAP1-TPDS is particularly relevant for ophthalmologists as it is associated with other malignant nonocular tumors.</p><p><strong>Objective: </strong>Retrospective analysis of patients ≤ 50 years with periocular BCC with respect to demographic, clinical and histological features for the identification of TPDS including BAP1 staining as a possible screening procedure for BAP1-TPDS.</p><p><strong>Material and methods: </strong>Identification of all patients ≤ 50 years with histologically confirmed BCC surgically treated at this hospital in the period 1996-2024. Documentation of the localization and histological subtype as well as evaluation of the immunohistochemical BAP1 staining.</p><p><strong>Results: </strong>During the observational period 38 patients ≤ 50 years with a BCC of the ocular adnexa were identified including 5 patients with multiple BCC. The average age of the patients at the time of excision was 42.7 years. The histological growth pattern was predominantly nodular (89%) and the localization of the tumors was in decreasing order the lower eyelid (53%), medial eyelid angle (26%) and upper eyelid (21%). Of the patients two had a TPDS (Gorlin-Goltz syndrome and xeroderma pigmentosum). The majority of the tumors examined showed a clear BAP1 staining reaction (89%), A proportion of positive tumor cells below 25% was present in only 4 patients.</p><p><strong>Conclusion: </strong>In the case of patients ≤ 50 years with BCC or with other tumor entities, a TPDS should be considered. The BAP1 staining is interesting in this respect as it could represent an economically favorable screening method for a BAP1-TPDS and is possible without any substantial increase in labor costs.</p>","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"708-715"},"PeriodicalIF":0.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Ophthalmologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00347-025-02273-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Basal cell carcinoma (BCC) is rare in patients ≤ 50 years and can be associated with tumor predisposition syndromes (TPDS). The BAP1-TPDS is particularly relevant for ophthalmologists as it is associated with other malignant nonocular tumors.
Objective: Retrospective analysis of patients ≤ 50 years with periocular BCC with respect to demographic, clinical and histological features for the identification of TPDS including BAP1 staining as a possible screening procedure for BAP1-TPDS.
Material and methods: Identification of all patients ≤ 50 years with histologically confirmed BCC surgically treated at this hospital in the period 1996-2024. Documentation of the localization and histological subtype as well as evaluation of the immunohistochemical BAP1 staining.
Results: During the observational period 38 patients ≤ 50 years with a BCC of the ocular adnexa were identified including 5 patients with multiple BCC. The average age of the patients at the time of excision was 42.7 years. The histological growth pattern was predominantly nodular (89%) and the localization of the tumors was in decreasing order the lower eyelid (53%), medial eyelid angle (26%) and upper eyelid (21%). Of the patients two had a TPDS (Gorlin-Goltz syndrome and xeroderma pigmentosum). The majority of the tumors examined showed a clear BAP1 staining reaction (89%), A proportion of positive tumor cells below 25% was present in only 4 patients.
Conclusion: In the case of patients ≤ 50 years with BCC or with other tumor entities, a TPDS should be considered. The BAP1 staining is interesting in this respect as it could represent an economically favorable screening method for a BAP1-TPDS and is possible without any substantial increase in labor costs.